Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review

Clicks: 396
ID: 10019
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #9 of 90 articles by views in disease markers

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Backgrounds. The objective of the present research was to systematically revise the international literature about the genetic biomarkers related to oral cancer (OC) evaluating the recent findings in clinical studies. Methods. A comprehensive review of the current literature was conducted according to the PRISMA guidelines by accessing the NCBI PubMed database. The authors conducted the search of articles in the English language published from 2008 to 2018. The present systematic review included only papers with significant results about correlation between wound healing, genetic alteration, and OC. Prognostic capacity of genetic markers was not evaluated in vivo. Results. The first analysis with filters recorded about 1884 published papers. Beyond reading and consideration of suitability, only 20 and then 8 papers, with case report exclusion, were recorded for the revision. Conclusion. All the researches recorded the proteomic and genetic alterations in OC human biopsy cells. The gene modification level in the different studies, compared with samples of healthy tissues, has always been statistically significant, but it is not possible to associate publications with each other because each job is based on the measurement of different biomarkers and gene targets. Further investigations should be required in order to state scientific evidence about a clear advantage of using these biomarkers for diagnostic purpose.
Reference Key
gabriele2019moleculardisease Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cervino, Gabriele;Fiorillo, Luca;Herford, Alan Scott;Romeo, Umberto;Bianchi, Alberto;Crimi, Salvatore;D’Amico, Cesare;De Stefano, Rosa;Troiano, Giuseppe;Santoro, Rossella;Laino, Luigi;Laino, Gregorio;Cicciù, Marco;Cervino, Gabriele;Fiorillo, Luca;Herford, Alan Scott;Romeo, Umberto;Bianchi, Alberto;Crimi, Salvatore;D’Amico, Cesare;De Stefano, Rosa;Troiano, Giuseppe;Santoro, Rossella;Laino, Luigi;Laino, Gregorio;Cicciù, Marco;
Journal disease markers
Year 2019
DOI
10.1155/2019/8040361
URL
https://www.hindawi.com/journals/dm/2019/8040361/abs/
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.